220. Rapidly progressive glomerulonephritis
[
2 clinical trials,
4 drugs（DrugBank:
2 drugs),
1 target gene / 1 target pathway ]
Searched query = "Rapidly progressive glomerulonephritis"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02647255 | March 2016 | 10 September 2018 | Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy | Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study) | Glomerulonephritis, IGA;Kidney Diseases;Acute Renal Insufficiency;Rapidly Progressive Glomerulonephritis | Procedure: Plasma Exchange (PE);Drug: Methylprednisolone pulse | Peking University First Hospital | Recruiting | 14 Years | 65 Years | All | 150 | Phase 2/Phase 3 | China | |
| 2 | NCT00354198 | August 2006 | 19 February 2015 | Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis | Clinical Efficacy of Combined Pentoxifylline and Conventional Immunosuppressive Regimens on Patients With Rapidly Progressive Glomerulonephritis | Glomerulonephritis | Drug: pentoxifylline;Drug: corticosteroids | National Taiwan University Hospital | National Science Council, Taiwan | Not recruiting | 20 Years | 80 Years | Both | 7 | Phase 3 | Taiwan |